Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hair growth control by immunosuppression.

× No keyword cloud information.

11 in total

1. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.

Authors: R Paus; B Handjiski; S Eichmüller; B M Czarnetzki
Journal: Am J Pathol Date: 1994-04 Impact factor: 4.307

Review 2. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes.

Authors: A Rao
Journal: Immunol Today Date: 1994-06

3. Mast cell involvement in murine hair growth.

Authors: R Paus; M Maurer; A Slominski; B M Czarnetzki
Journal: Dev Biol Date: 1994-05 Impact factor: 3.582

Review 4. The mechanism of action of cyclosporin A and FK506.

Authors: S L Schreiber; G R Crabtree
Journal: Immunol Today Date: 1992-04

5. A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A.

Authors: R Paus; B Handjiski; B M Czarnetzki; S Eichmüller
Journal: J Invest Dermatol Date: 1994-08 Impact factor: 8.551

6. The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration.

Authors: R Paus; K S Stenn; R E Link
Journal: Lab Invest Date: 1989-03 Impact factor: 5.662

Review 7. Topical FK506--clinical potential or laboratory curiosity?

Authors: A I Lauerma; H I Maibach
Journal: Dermatology Date: 1994 Impact factor: 5.366

8. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.

Authors: T Iwabuchi; T Maruyama; Y Sei; K Adachi
Journal: J Dermatol Sci Date: 1995-01 Impact factor: 4.563

9. Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant.

Authors: H Jiang; S Yamamoto; R Kato
Journal: J Invest Dermatol Date: 1995-04 Impact factor: 8.551

10. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

Authors:
Journal: Lancet Date: 1994-08-13 Impact factor: 79.321

5 in total

1. Re-Evaluating Cyclosporine A as a Hair Growth-Promoting Agent in Human Scalp Hair Follicles.

Authors: Nathan J Hawkshaw; Iain S Haslam; David M Ansell; Asim Shamalak; Ralf Paus
Journal: J Invest Dermatol Date: 2015-03-31 Impact factor: 8.551

2. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.

Authors: M Maurer; B Handjiski; R Paus
Journal: Am J Pathol Date: 1997-04 Impact factor: 4.307

Review 3. Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle.

Authors: Mikhail Geyfman; Maksim V Plikus; Elsa Treffeisen; Bogi Andersen; Ralf Paus
Journal: Biol Rev Camb Philos Soc Date: 2014-11-19

4. Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model.

Authors: Wenrong Xu; Weixin Fan; Kun Yao
Journal: J Biomed Res Date: 2012-03-29

5. Mycophenolate antagonizes IFN-γ-induced catagen-like changes via β-catenin activation in human dermal papilla cells and hair follicles.

Authors: Sunhyo Ryu; Yonghee Lee; Moo Yeol Hyun; Sun Young Choi; Kwan Ho Jeong; Young Min Park; Hoon Kang; Kui Young Park; Cheryl A Armstrong; Andrew Johnson; Peter I Song; Beom Joon Kim
Journal: Int J Mol Sci Date: 2014-09-22 Impact factor: 5.923

5 in total